Found 0 matching trials
Lab Study of MQX-503 in Treatment of Raynaud's
PHASE2The purpose of this study is to determine, in comparison to a placebo contr...
Location
Johns Hopkins Bayview Medical Center
Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon
PHASE2Raynaud's phenomenon (RP) is a disorder of the digital blood vessels result...
Location
Salford Royal NHS foundation Trust
PF-00489791 For The Treatment Of Raynaud's
PHASE2The investigators propose that once daily administration of PF-00489791, a ...
Location
Stanford Hospital and Outpatient Center
Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease
PHASE3The main objective is to assess the feasibility of treatment by injecting b...
Location
University Hospital Toulouse
Tadalafil-Delivra and Raynaud's Phenomenon
N/AA 4-8 week observational feasibility study of the use of the use of Tadalaf...
Location
St. Joseph's Healthcare
Phototherapy For Treatment Of Raynaud's Phenomenon
NATo determine if blue light therapy can improve the symptoms of Raynaud's ph...
Location
University of Minnesota
Emerging Indications for Hyperbaric Oxygen Treatment
PHASE4This study will evaluate the effectiveness of hyperbaric oxygen therapy (HB...
Location
Multiple Locations
PORH and Response to Cold in Raynaud's Phenomenon.
NAThe main objective of the study is to determine if implication of epoxy-eic...
Location
Centre d'investigation clinique CIC1406
Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator
PHASE2Patients with Raynaud's phenomenon suffer from painful attacks triggered by...
Location
Multiple Locations
Metabolomic Analysis of Systemic Sclerosis
N/ACurrently investigators do not have diagnostic and prognostic markers for S...